Live Breaking News & Updates on Avalo Therapeutics Inc

Stay updated with breaking news from Avalo therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Short Interest in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Declines By 20.3%

Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) saw a significant drop in short interest in May. As of May 15th, there was short interest totalling 83,100 shares, a drop of 20.3% from the April 30th total of 104,300 shares. Based on an average trading volume of 658,200 shares, the days-to-cover ratio is currently 0.1 […] ....

Acadian Asset Management , Ikarian Capital , Affinity Asset Advisors , Avalo Therapeutics Inc , Avalo Therapeutics , Get Free Report , Therapeutics Stock Down , Asset Management , Avalo Therapeutics Daily ,

Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates

Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Christopher Sullivan , Chris Brinzey , Garry Neil , Avalo Therapeutics Inc , Exchange Commission , Program Updates , Almatabio Inc , Reports First Quarter , Provides Business , Chief Executive Officer , Seriesc Preferred Stock , Seriesd Preferred Stock , Seriese Preferred Stock , Herpesvirus Entry Mediator , Private Securities Litigation Reform Act , Middle East ,

Short Interest in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Decreases By 32.0%

Short Interest in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Decreases By 32.0%
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Acadian Asset Management , Exchange Commission , Avalo Therapeutics Inc , Avalo Therapeutics , Get Free Report , Asset Management , Free Report , Avalo Therapeutics Daily ,